IL37 and hepatocellular carcinoma: Subsequently, it was confirmed in mouse hepatocellular carcinoma model that IL-37 has the effect of inhibiting tumor growth, possibly by increasing the recruitment of CD57+ NK cells to kill cancer cells [21].